Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M98,430Revenue (TTM) $M37,870Net Margin (%)6.5Altman Z-Score1.1
Enterprise Value $M122,844EPS (TTM) $1.0Operating Margin %12.5Piotroski F-Score7
P/E(ttm)37.8Beneish M-Score-2.9Pre-tax Margin (%)10.3Higher ROA y-yY
Price/Book89.310-y EBITDA Growth Rate %-1.9Quick Ratio0.4Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %-8.5Current Ratio0.6Lower Leverage y-yY
Price/Free Cash Flow15.7y-y EBITDA Growth Rate %108ROA % (ttm)3.3Higher Current Ratio y-yN
Dividend Yield %5.0PEG--ROE % (ttm)221Less Shares Outstanding y-yN
Payout Ratio %200Shares Outstanding M2,459ROIC % (ttm)14.6Gross Margin Increase y-yY

Gurus Latest Trades with GSK

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

GSK is held by these investors:



GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$2284.45view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.1491.96view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29667.11view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12238.17view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14189.86view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12238.17view

Press Releases about GSK :

Quarterly/Annual Reports about GSK:

    News about GSK:

    Articles On GuruFocus.com
    Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of Sep 18 2017 
    FDA Advisory Committee votes unanimously for Shingrix (HZ/su) in the US for prevention of herpes zos Sep 13 2017 
    Everybody Wins With GlaxoSmithKline's Latest Deal Sep 07 2017 
    GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO Sep 07 2017 
    GlaxoSmithKline's 5% Yield Carries Considerable Risk Aug 31 2017 
    Most Popular Drug Manufacturers of 2nd Quarter Aug 29 2017 
    Express Scripts Is on Sale Aug 28 2017 
    Stocks That Fell to 3-Year Lows in the Week of August 11 Aug 13 2017 
    What Financial Modeling Says About Gilead Sciences Jul 26 2017 
    GSK ships 2017-18 seasonal influenza vaccines for US market Jul 14 2017 

    More From Other Websites
    Pharma Stock Roundup: Pfizer Files Suit against J&J, Supernus Hit by Study Update Sep 22 2017
    Glaxo-Innoviva's Triple Combo Inhaler Positive in Phase III Sep 21 2017
    How GlaxoSmithKline (GSK) Stock Stands Out in a Strong Industry Sep 21 2017
    Is GlaxoSmithKline plc (GSK) a Suitable Value Stock? Sep 20 2017
    GSK's new triple lung drug beats other modern inhalers in study Sep 20 2017
    GSK and Innoviva Report Positive Headline Results from IMPACT Study Showing Single Inhaler Triple... Sep 20 2017
    FDA OKs Glaxo's inhaler, first one to combine 3 medicines Sep 19 2017
    Glaxo/Innoviva's Triple Combo Therapy Gets FDA Nod for COPD Sep 19 2017
    [$$] Andrew Witty jumps into biotech venture capital Sep 19 2017
    GlaxoSmithKline breathes easier as U.S. approves triple lung drug Sep 19 2017
    Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of... Sep 18 2017
    U.S. FDA approves GSK's three-in-one drug inhaler for COPD Sep 18 2017
    Trelegy Ellipta Approved as the First Once-Daily Single Inhaler Triple Therapy for the Treatment of... Sep 18 2017
    What Analysts Recommend for Novartis in September 2017 Sep 18 2017
    3 High-Yield Healthcare Stocks Sep 18 2017
    Glaxo's Triple Therapy COPD Inhaler Gets CHMP Nod in the EU Sep 18 2017
    France's Neovacs takes on GSK and AstraZeneca in battle to treat lupus Sep 15 2017
    Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO Sep 15 2017
    GSK's three-in-one inhaler gets positive opinion from EU agency Sep 15 2017
    Trelegy Ellipta Once-Daily Single Inhaler Triple Therapy Receives Positive Opinion from the CHMP in... Sep 15 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat

    {{numOfNotice}}